These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31105135)

  • 1. [Arenavirus research and antiviral candidate].
    Tani H; Shuzo U
    Uirusu; 2018; 68(1):51-62. PubMed ID: 31105135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arenavirus infections].
    Tani H; Fukushi S; Yoshikawa T; Saijo M; Morikawa S
    Uirusu; 2012; 62(2):229-38. PubMed ID: 24153233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoonotic aspects of arenavirus infections.
    Charrel RN; de Lamballerie X
    Vet Microbiol; 2010 Jan; 140(3-4):213-20. PubMed ID: 19748747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arenavirus Quasispecies and Their Biological Implications.
    Grande-Pérez A; Martin V; Moreno H; de la Torre JC
    Curr Top Microbiol Immunol; 2016; 392():231-76. PubMed ID: 26472215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research efforts to control highly pathogenic arenaviruses: a summary of the progress and gaps.
    Kerber R; Reindl S; Romanowski V; Gómez RM; Ogbaini-Emovon E; Günther S; ter Meulen J
    J Clin Virol; 2015 Mar; 64():120-7. PubMed ID: 25549822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses.
    de la Torre JC
    Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E57-64. PubMed ID: 19751403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse genetics approaches to combat pathogenic arenaviruses.
    de la Torre JC
    Antiviral Res; 2008 Dec; 80(3):239-50. PubMed ID: 18782590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel drug discovery approaches for treating arenavirus infections.
    Pasquato A; Kunz S
    Expert Opin Drug Discov; 2016; 11(4):383-93. PubMed ID: 26882218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arenaviruses and hantaviruses: from epidemiology and genomics to antivirals.
    Charrel RN; Coutard B; Baronti C; Canard B; Nougairede A; Frangeul A; Morin B; Jamal S; Schmidt CL; Hilgenfeld R; Klempa B; de Lamballerie X
    Antiviral Res; 2011 May; 90(2):102-14. PubMed ID: 21356244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel antiviral strategies to combat human Arenavirus infections.
    Kunz S; de la Torre JC
    Curr Mol Med; 2005 Dec; 5(8):735-51. PubMed ID: 16375709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity.
    Miranda PO; Cubitt B; Jacob NT; Janda KD; de la Torre JC
    ACS Infect Dis; 2018 May; 4(5):815-824. PubMed ID: 29405696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arenaviruses other than Lassa virus.
    Charrel RN; de Lamballerie X
    Antiviral Res; 2003 Jan; 57(1-2):89-100. PubMed ID: 12615305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses.
    Lee AM; Rojek JM; Spiropoulou CF; Gundersen AT; Jin W; Shaginian A; York J; Nunberg JH; Boger DL; Oldstone MB; Kunz S
    J Biol Chem; 2008 Jul; 283(27):18734-42. PubMed ID: 18474596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines.
    Martinez-Sobrido L; de la Torre JC
    Expert Rev Vaccines; 2016 Sep; 15(9):1113-21. PubMed ID: 27118328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arenavirus extinction through lethal mutagenesis.
    de la Torre JC
    Virus Res; 2005 Feb; 107(2):207-14. PubMed ID: 15649566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.
    Neuman BW; Bederka LH; Stein DA; Ting JP; Moulton HM; Buchmeier MJ
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4631-8. PubMed ID: 21825302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
    Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the vascular endothelium in arenavirus haemorrhagic fevers.
    Kunz S
    Thromb Haemost; 2009 Dec; 102(6):1024-9. PubMed ID: 19967131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and patient management of Lujo hemorrhagic fever.
    Sewlall NH; Richards G; Duse A; Swanepoel R; Paweska J; Blumberg L; Dinh TH; Bausch D
    PLoS Negl Trop Dis; 2014; 8(11):e3233. PubMed ID: 25393244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of live-attenuated arenavirus vaccines based on codon deoptimization.
    Cheng BY; Ortiz-Riaño E; Nogales A; de la Torre JC; Martínez-Sobrido L
    J Virol; 2015 Apr; 89(7):3523-33. PubMed ID: 25589652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.